178 related articles for article (PubMed ID: 7533357)
1. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
Platz KP; Mueller AR; Zytowski M; Bechstein WO; Blumhardt G; Lobeck H; Neuhaus P
Transplant Proc; 1995 Feb; 27(1):1111-3. PubMed ID: 7533357
[No Abstract] [Full Text] [Related]
2. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
3. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
[No Abstract] [Full Text] [Related]
4. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
Bismuth H
Transplant Proc; 1995 Feb; 27(1):45-9. PubMed ID: 7533415
[No Abstract] [Full Text] [Related]
5. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):679-88. PubMed ID: 7679840
[TBL] [Abstract][Full Text] [Related]
6. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
[TBL] [Abstract][Full Text] [Related]
7. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
[No Abstract] [Full Text] [Related]
8. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R
Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227
[No Abstract] [Full Text] [Related]
9. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
Herget S; Heemann U; Friedrich J; Kribben A; Wagner K; Philipp T
Clin Nephrol; 1996 May; 45(5):352-4. PubMed ID: 8738671
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression is not related to the response to steroids in acute liver rejection.
Bercedo J; Jiménez C; Moreno E; García MA; Palomo JC; Loinaz C; Marcello M; Moreno C; Chamorro A; Manzanera M
Transplant Proc; 1995 Aug; 27(4):2328-9. PubMed ID: 7652830
[No Abstract] [Full Text] [Related]
11. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
[TBL] [Abstract][Full Text] [Related]
12. Does initial graft function influence the outcome after liver transplantation?
Mueller AR; Platz KP; Krause P; Neuhaus R; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
[No Abstract] [Full Text] [Related]
13. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
[No Abstract] [Full Text] [Related]
14. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
15. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
[No Abstract] [Full Text] [Related]
16. OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trial.
Höckerstedt K; Ericzon BG; Bismuth H; Chapuis Y; Farges O; Faure JL; Galmarini D; Houssin D; Lynch SV; Miguet J
Transplant Proc; 1993 Feb; 25(1 Pt 1):556-7. PubMed ID: 8438412
[No Abstract] [Full Text] [Related]
17. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Scott-Douglas N; Zimmerman D; Klassen J
Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
[No Abstract] [Full Text] [Related]
18. Role of cyclosporine rescue therapy in steroid resistant rejections.
Sharma RK; Elhence R; Kher V; Gupta A; Kumar A; Bhandari M; Agrawal S
Transplant Proc; 1994 Oct; 26(5):2556-7. PubMed ID: 7940789
[No Abstract] [Full Text] [Related]
19. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
[No Abstract] [Full Text] [Related]
20. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
